RARE : Ultragenyx Pharmaceutical stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-05-26 |
|---|---|---|---|---|
| 2023 | $55.78 | $50.66 | $63.11 | 11.94% |
| 2024 | $74.99 | $65.97 | $79.68 | 50.48% |
| 2025 | $76.69 | $69.78 | $79.72 | 53.9% |
| 2026 | $63.17 | $60.62 | $68.23 | 26.77% |
| 2027 | $63.87 | $55.69 | $67.63 | 28.17% |
| 2028 | $45.9 | $39.71 | $52.73 | -7.9% |
| 2029 | $38.52 | $33.19 | $45.86 | -22.69% |
| 2030 | $29.47 | $28.17 | $32.36 | -40.86% |
| 2031 | $44.83 | $29.3 | $64.58 | -10.04% |
| 2032 | $56.93 | $49.1 | $64.09 | 14.25% |
| 2033 | $48.54 | $46.65 | $52.0 | -2.58% |
The 8 Wall Street analysts offering Ultragenyx Pharmaceutical stock forecast in the last 6 months have average price target of
$84.75 with a high forecast of $114.0 and a low forecast of $48.0.
The average Ultragenyx Pharmaceutical stock forecast represents a 70.08%
increase from the last price of $49.8300018310547.
From AI system, total return is 2366.52% from 4098 forecasts.
For Ultragenyx Pharmaceutical stock forecast for 2023, 7 predictions are offered for each month of 2023 with average Ultragenyx Pharmaceutical stock
forecast of $55.78, a high forecast of $63.11, and a low forecast of $50.66.
The average Ultragenyx Pharmaceutical stock forecast 2023 represents a 11.94%
increase from the last price of $49.8300018310547.
For Ultragenyx Pharmaceutical stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Ultragenyx Pharmaceutical stock
forecast of $74.99, a high forecast of $79.68, and a low forecast of $65.97.
The average Ultragenyx Pharmaceutical stock forecast 2024 represents a 50.48%
increase from the last price of $49.8300018310547.
For Ultragenyx Pharmaceutical stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Ultragenyx Pharmaceutical stock
forecast of $63.17, a high forecast of $68.23, and a low forecast of $60.62.
The average Ultragenyx Pharmaceutical stock forecast 2026 represents a 26.77%
increase from the last price of $49.8300018310547.
For Ultragenyx Pharmaceutical stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Ultragenyx Pharmaceutical stock
forecast of $45.9, a high forecast of $52.73, and a low forecast of $39.71.
The average Ultragenyx Pharmaceutical stock forecast 2028 represents a -7.9%
decrease from the last price of $49.8300018310547.
For Ultragenyx Pharmaceutical stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Ultragenyx Pharmaceutical stock
forecast of $44.83, a high forecast of $64.58, and a low forecast of $29.3.
The average Ultragenyx Pharmaceutical stock forecast 2031 represents a -10.04%
decrease from the last price of $49.8300018310547.
For Ultragenyx Pharmaceutical stock forecast for 2033 (10 year), 5 predictions are offered for each month of 2033 with average Ultragenyx Pharmaceutical stock
forecast of $48.54, a high forecast of $52.0, and a low forecast of $46.65.
The average Ultragenyx Pharmaceutical stock forecast 2033 represents a -2.58%
decrease from the last price of $49.8300018310547.
Please, see more forecasts below.
RARE : Ultragenyx Pharmaceutical stock forecast by Wall Street Analysts
The average Ultragenyx Pharmaceutical stock forecast from last 6 month is $84.75, and this show a 1.52% increase in average from the prior price target of the each prediction. Also, this average forecast of $84.75 represents a -1.12% decrease from the past average forecast of $85.71, 6 months ago from 14 wall street analysts.
Ultragenyx Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-05-29 | $50.65 | 1.64% |
| 2023-05-30 | $50.57 | -0.16% |
| 2023-05-31 | $50.76 | 0.38% |
| 2023-06-01 | $50.61 | -0.29% |
| 2023-06-02 | $50.02 | -1.18% |
RARE : Long term Ultragenyx Pharmaceutical stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Jun. is $50.66 , for 2024 May. is $74.27 , for 2027 May. is $67.30 , for 2028 May. is $39.71 , for 2032 May. is $58.20 , and for 2033 May. is $52.00.
RARE : Ultragenyx Pharmaceutical stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jun. | $50.66 | 1.66% |
| 2023 Jul. | $51.44 | 1.55% |
| 2023 Aug. | $52.98 | 2.99% |
| 2023 Sep. | $55.03 | 3.86% |
| 2023 Oct. | $57.28 | 4.10% |
| 2023 Nov. | $59.95 | 4.65% |
| 2023 Dec. | $63.11 | 5.28% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $65.97 | 4.54% |
| 2024 Feb. | $68.70 | 4.12% |
| 2024 Mar. | $70.84 | 3.13% |
| 2024 Apr. | $72.70 | 2.63% |
| 2024 May. | $74.27 | 2.15% |
| 2024 Jun. | $75.72 | 1.96% |
| 2024 Jul. | $76.91 | 1.57% |
| 2024 Aug. | $77.85 | 1.22% |
| 2024 Sep. | $78.59 | 0.95% |
| 2024 Oct. | $79.11 | 0.65% |
| 2024 Nov. | $79.47 | 0.46% |
| 2024 Dec. | $79.68 | 0.26% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $79.72 | 0.05% |
| 2025 Feb. | $79.68 | -0.05% |
| 2025 Mar. | $79.47 | -0.27% |
| 2025 Apr. | $79.11 | -0.44% |
| 2025 May. | $78.66 | -0.57% |
| 2025 Jun. | $78.16 | -0.64% |
| 2025 Jul. | $77.65 | -0.65% |
| 2025 Aug. | $77.00 | -0.84% |
| 2025 Sep. | $75.69 | -1.70% |
| 2025 Oct. | $73.70 | -2.62% |
| 2025 Nov. | $71.62 | -2.83% |
| 2025 Dec. | $69.78 | -2.56% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $68.23 | -2.22% |
| 2026 Feb. | $66.68 | -2.28% |
| 2026 Mar. | $65.21 | -2.19% |
| 2026 Apr. | $64.05 | -1.78% |
| 2026 May. | $63.15 | -1.41% |
| 2026 Jun. | $62.22 | -1.46% |
| 2026 Jul. | $61.27 | -1.53% |
| 2026 Aug. | $60.69 | -0.95% |
| 2026 Sep. | $60.62 | -0.10% |
| 2026 Oct. | $61.15 | 0.87% |
| 2026 Nov. | $61.95 | 1.31% |
| 2026 Dec. | $62.77 | 1.32% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $63.56 | 1.26% |
| 2027 Feb. | $64.40 | 1.34% |
| 2027 Mar. | $65.38 | 1.52% |
| 2027 Apr. | $66.45 | 1.63% |
| 2027 May. | $67.30 | 1.28% |
| 2027 Jun. | $67.63 | 0.49% |
| 2027 Jul. | $67.23 | -0.58% |
| 2027 Aug. | $65.93 | -1.94% |
| 2027 Sep. | $63.67 | -3.43% |
| 2027 Oct. | $60.94 | -4.28% |
| 2027 Nov. | $58.25 | -4.43% |
| 2027 Dec. | $55.69 | -4.39% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $52.73 | -5.31% |
| 2028 Feb. | $48.81 | -7.44% |
| 2028 Mar. | $44.41 | -9.00% |
| 2028 Apr. | $41.01 | -7.67% |
| 2028 May. | $39.71 | -3.17% |
| 2028 Jun. | $40.64 | 2.35% |
| 2028 Jul. | $43.07 | 5.97% |
| 2028 Aug. | $46.04 | 6.89% |
| 2028 Sep. | $48.50 | 5.36% |
| 2028 Oct. | $49.43 | 1.92% |
| 2028 Nov. | $48.88 | -1.11% |
| 2028 Dec. | $47.52 | -2.78% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $45.86 | -3.50% |
| 2029 Feb. | $44.12 | -3.80% |
| 2029 Mar. | $42.42 | -3.83% |
| 2029 Apr. | $40.90 | -3.59% |
| 2029 May. | $39.63 | -3.12% |
| 2029 Jun. | $38.54 | -2.76% |
| 2029 Jul. | $37.45 | -2.81% |
| 2029 Aug. | $36.32 | -3.02% |
| 2029 Sep. | $35.32 | -2.76% |
| 2029 Oct. | $34.59 | -2.05% |
| 2029 Nov. | $33.94 | -1.89% |
| 2029 Dec. | $33.19 | -2.20% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $32.36 | -2.52% |
| 2030 Feb. | $31.51 | -2.61% |
| 2030 Mar. | $30.74 | -2.46% |
| 2030 Apr. | $30.07 | -2.16% |
| 2030 May. | $29.52 | -1.84% |
| 2030 Jun. | $29.06 | -1.55% |
| 2030 Jul. | $28.69 | -1.27% |
| 2030 Aug. | $28.42 | -0.95% |
| 2030 Sep. | $28.25 | -0.62% |
| 2030 Oct. | $28.17 | -0.26% |
| 2030 Nov. | $28.26 | 0.30% |
| 2030 Dec. | $28.60 | 1.21% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $29.30 | 2.43% |
| 2031 Feb. | $30.39 | 3.75% |
| 2031 Mar. | $31.60 | 3.96% |
| 2031 Apr. | $32.88 | 4.07% |
| 2031 May. | $35.78 | 8.82% |
| 2031 Jun. | $39.55 | 10.54% |
| 2031 Jul. | $44.17 | 11.68% |
| 2031 Aug. | $49.92 | 13.01% |
| 2031 Sep. | $55.73 | 11.65% |
| 2031 Oct. | $60.48 | 8.51% |
| 2031 Nov. | $63.52 | 5.02% |
| 2031 Dec. | $64.58 | 1.68% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $64.09 | -0.76% |
| 2032 Feb. | $62.64 | -2.26% |
| 2032 Mar. | $60.81 | -2.93% |
| 2032 Apr. | $59.22 | -2.62% |
| 2032 May. | $58.20 | -1.72% |
| 2032 Jun. | $57.39 | -1.38% |
| 2032 Jul. | $56.47 | -1.61% |
| 2032 Aug. | $55.47 | -1.77% |
| 2032 Sep. | $54.68 | -1.42% |
| 2032 Oct. | $53.62 | -1.94% |
| 2032 Nov. | $51.49 | -3.98% |
| 2032 Dec. | $49.10 | -4.64% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $47.26 | -3.74% |
| 2033 Feb. | $46.65 | -1.31% |
| 2033 Mar. | $47.43 | 1.68% |
| 2033 Apr. | $49.38 | 4.10% |
| 2033 May. | $52.00 | 5.30% |
Frequently Asked Questions about Ultragenyx Pharmaceutical stock forecast
Is Ultragenyx Pharmaceutical a good long term stock?
From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to Tudal, the Ultragenyx Pharmaceutical stock price forecast for 2023 Jun. is $50.6569088973257 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to Tudal, the Ultragenyx Pharmaceutical stock price forecast for 2024 May. is $74.2714799423862 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to Tudal, the Ultragenyx Pharmaceutical stock price forecast for 2027 May. is $67.2973272859808 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock cannot be a good investment choice. According to Tudal, the Ultragenyx Pharmaceutical stock price forecast for 2028 May. is $39.7057759168544 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to Tudal, the Ultragenyx Pharmaceutical stock price forecast for 2032 May. is $58.1966881227461 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to Tudal, the Ultragenyx Pharmaceutical stock price forecast for 2033 May. is $51.9953532297843
Is Ultragenyx Pharmaceutical stock overvalued?
Ultragenyx Pharmaceutical (RARE) stock is expected to go UP . Therefore, Tudal would say that Ultragenyx Pharmaceutical (RARE) stock is NOT overvalued.
Will Ultragenyx Pharmaceutical stock price go up?
Yes. The Ultragenyx Pharmaceutical stock price forecast for 2024 May. is $74.2714799423862
Is Ultragenyx Pharmaceutical stock a good buy now?
Since closing price on 2023-05-26 is $49.8300018310547 and forecast for 2024 May. is $74.27, Ultragenyx Pharmaceutical stock is a good 1 year investment.